Welcome to the 12th Aging Research and Drug Discovery Meeting (IMAGE)
Caption
Taking place from August 25–29 at the University of Copenhagen, ARDD 2025 will bring together an unparalleled roster of talent: two Nobel laureates, eight of the top ten experts in longevity research, more than half of the top-ranked scientists in medicine and health recognized by the Nature Index 2025, and representatives from leading research institutions. Together, participants will delve into the latest breakthroughs in areas such as cell simulation, deep aging biomarkers, and cellular aging mechanisms, driving the field ever closer to achieving healthy longevity for all.
During ARDD 2025, Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine, will join leaders from Eli Lilly, Biogen, and Fosun Pharma to discuss advances in longevity in the pharmaceutical industry, scheduled for 17:40–18:40 CET on August 26. He will also deliver a dedicated talk on the rational design of geroprotectors and clinical protocols at 19:00–19:20 CET on August 29. Meanwhile, Insilico's software and business development team will be actively engaged throughout the conference, with senior scientist Fedor Galkin presenting novel target discovery for IPF and aging research at 19:20–19:40 CET on August 27.
Credit
Insilico Medicine
Usage Restrictions
Insilico Medicine
License
Original content